基于[18F]FDG PET/CT与多序列MRI的多模态影像组学分析:用于鼻咽癌预后预测
结果显示,单一模态模型预测效能有限(测试队列C-index 0.539-0.664),而PET/CT与多序列MRI整合模型表现最佳(测试队列C-index 0.745,95%CI 0.619-0.865),临床-影像组学列线图进一步改善预后评估。
要点
- 单一模态影像组学模型对鼻咽癌PFS预测效能有限,测试队列C-index仅0.539-0.664。
- PET/CT联合多序列MRI的整合模型预测效能最佳,测试队列C-index达0.745。
- 临床-影像组学列线图可进一步改善预后评估,并展现满意的区分度与校准度。
核心结论
- 基于PET/CT与多序列MRI的多模态影像组学分析可潜在提高鼻咽癌患者无进展生存期的预测效能。
- 单一模态影像组学模型在鼻咽癌预后评估中表现有限。
- 放射组学特征与临床因素结合的列线图可进一步改善预后预测,并展示满意的区分度、校准度和净获益。
研究设计与样本
- 从PET、CT、T1、T1C、T2五种模态/序列的原发肿瘤体积中各提取1906个影像组学特征。
- 采用单变量Cox模型和相关性分析进行特征选择,多变量Cox模型建立影像组学标签。
- 评估5个单一模态模型和12个多模态模型(3种整合×4种融合策略)的预后性能,指标为C-index和log-rank检验。
- 构建临床-影像组学列线图,并通过区分度、校准曲线和决策曲线分析(DCA)评估其临床效用。
诊断标准与关键数值
- 单一模态影像组学标签在测试队列中的C-index为0.539-0.664。
- PET/CT与MRI整合模型在测试队列中表现最佳,C-index为0.745(95%CI,0.619-0.865),log-rank检验p<0.05。
- 不同融合策略之间预测性能差异轻微,但特征级融合值得更多关注。
- 临床-影像组学列线图在区分度、校准度和决策曲线分析中均显示满意结果。
临床应用与阅片要点
- 对于鼻咽癌患者,可考虑联合PET/CT与多序列MRI的影像组学特征进行无进展生存期预测,而非依赖单一模态。
- 特征级融合策略可能具有潜在优势,但不同融合策略性能差异不大,需结合临床实际选择。
- 临床-影像组学列线图可用于辅助个体化预后评估,但需注意其基于回顾性数据,推广前需外部验证。
局限性
- 研究为单中心设计,未进行外部验证。
- 不同融合策略性能差异轻微,最佳融合策略尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether radiomics models developed from 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) PET/CT combined with multisequence MRI could contribute to predicting the progression-free survival (PFS) of nasopharyngeal carcinoma (NPC) patients.
METHODS: One hundred thirty-two NPC patients who underwent both PET/CT and MRI scanning were retrospectively enrolled (88 vs. 44 for training vs. testing). For each modality/sequence (i.e., PET, CT, T1, T1C, and T2), 1906 radiomics features were extracted from the primary tumor volume. Univariate Cox model and correlation analysis were used for feature selection. A multivariate Cox model was used to establish radiomics signature. Prognostic performances of 5 individual modality models and 12 multimodality models (3 integrations × 4 fusion strategies) were assessed by the concordance index (C-index) and log-rank test. A clinical-radiomics nomogram was built to explore the clinical utilities of radiomics signature, which was evaluated by discrimination, calibration curve, and decision curve analysis (DCA).
RESULTS: The radiomics signatures of individual modalities showed limited prognostic efficacy with a C-index of 0.539-0.664 in the testing cohort. Different fusion strategies exhibited a slight difference in predictive performance. The PET/CT and MRI integrated model achieved the best performance with a C-index of 0.745 (95% CI, 0.619-0.865) in the testing cohort (log-rank test, p < 0.05). Clinical-radiomics nomogram further improved the prognosis, which also showed satisfactory discrimination, calibration, and net benefit.
CONCLUSIONS: Multimodality radiomics analysis by combining PET/CT with multisequence MRI could potentially improve the efficacy of PFS prediction for NPC patients.
KEY POINTS: • Individual modality radiomics models showed limited performance in prognosis evaluation for NPC patients. • Combined PET, CT and multisequence MRI radiomics signature could improve the prognostic efficacy. • Multilevel fusion strategies exhibit comparable performance but feature-level fusion deserves more attention.
引用
- Xu, Lv, Zhang, et al. Multimodality radiomics analysis based on [18F]FDG PET/CT imaging and multisequence MRI: application to nasopharyngeal carcinoma prognosis. Eur Radiol. 2023. PMID: 37060444. doi:10.1007/s00330-023-09606-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。